title: [DRESS syndrome].
authors.forename: Aida
authors.initials: A
authors.lastname: Khaled
authors.forename: Asmahene
authors.initials: A
authors.lastname: Souissi
authors.forename: Faten
authors.initials: F
authors.lastname: Zeglaoui
authors.forename: Nadia
authors.initials: N
authors.lastname: El Fekih
authors.forename: Riadh
authors.initials: R
authors.lastname: Daghfous
authors.forename: Becima
authors.initials: B
authors.lastname: Fazaa
mesh_terms: D000293:Adolescent; D000328:Adult; D000493:Allopurinol / Q000009:adverse effects; D000890:Anti-Infective Agents / Q000009:adverse effects; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D000927:Anticonvulsants / Q000009:adverse effects; D002220:Carbamazepine / Q000009:adverse effects; D002648:Child; D004338:Drug Combinations; D003875:Drug Eruptions / Q000209:etiology*; D004802:Eosinophilia / Q000139:chemically induced*; D005076:Exanthema / Q000139:chemically induced; D005260:Female; D005944:Glucosamine / Q000009:adverse effects / Q000031:analogs & derivatives; D006074:Gout Suppressants / Q000009:adverse effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D011537:Pruritus / Q000139:chemically induced; D012189:Retrospective Studies; D012460:Sulfasalazine / Q000009:adverse effects; D013577:Syndrome; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000009:adverse effects; D055815:Young Adult
chemical_list: D000890:Anti-Infective Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000927:Anticonvulsants; D004338:Drug Combinations; D006074:Gout Suppressants; C028423:Salazopyrine; D002220:Carbamazepine; D012460:Sulfasalazine; D000493:Allopurinol; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D005944:Glucosamine